13 funding opportunities found in this category. Change the order of results: Newest First Oldest First Expiring Soonest Expiring Latest Lowest Award to Highest Highest Award to Lowest
James Ewing Foundation of the Society of Surgical Oncology and Susan G. Komen for the Cure 2013 Fall Clinical Investigator Award in Breast Cancer Research
Application deadline: Monday, July 8, 2013
Purpose: To promote patient-oriented research conducted by surgical oncologists in clinical and translational science.
Eligibility
Applicants must be surgical oncologists within 10 years of completion of training
Be full SSO members for at least 6 months prior to application submission to be eligible for the award
Applicants must commit to at least 25% effort for this award
Terms of the Award
The award will be funded for two years at $100,000 ($50,000 per year) beginning October 1, 2013. The Award concludes September 30, 2015.
The award is given to the sponsoring institution and may be used for partial support of applicant’s salary, research fellows or staff support, tuition, travel(no more than $2,000 per year) and/or supplies. No additional funds are available for paying indirect costs.
A brief year-one progress report with a financial update will be required by September 30, 2014. The JEF reserves the right to withhold the second year of support in the event of unsatisfactory progress.
A final report (not to exceed 4 pages) will be required before September 30, 2015. This should include a summary of the project, abstracts and publications acknowledged as supported by this award, and a financial report. Any unexpended funds from the scholarship are to be reimbursed back to JEF.
A brief (up to 10 minutes) presentation of results will be required at the March 2-5, 2016, SSO Annual Cancer Symposium in Boston, MA.
The James Ewing Foundation of the Society of Surgical Oncology requests a proposal in which the applicant plays a central role in the conduct of a specific clinical research project. This might include for example a leadership role in a clinical trial, in a prospective cancer outcomes study, or a translational research project related to a prospective clinical trial. The clinical research focus must be hypothesis-driven and must have a direct patient-oriented focus.
Clinical trials may be investigator-initiated, industry-driven or organized by a cooperative group. While the applicant need not be the principal investigator of the trial, nor the lead institutional investigator, the extent to which the applicant is involved in study design and conduct must be clearly articulated. Ideal applicants will be early to mid-career investigators with a track record of peer-reviewed research funding who are seeking additional extramural support to further clinical cancer research. Of note, this award is not intended to serve as a career development award for new investigators seeking to initiate their research careers. The track record of the applicant, scientific merit of the application, novelty and clinical impact of the anticipated results, and resources available to ensure completion of the study will comprise the review criteria.
Questions?
Contact the James Ewing Foundation of the Society of Surgical Oncology, Email: jef@surgonc.org, or phone 847-427-1400, ext. 111, M-F, 8:30 a.m. - 4:30 p.m. (CT).Address:9525 W. Bryn Mawr Ave., Suite 870 Rosemont, Illinois 60018. Web: www.surgonc.org
ISCTR-American College of Cardiology Foundation Cardiovascular Translational Research Scholarship
sponsored by Dignity Health, St. John's Hospital
The purpose of the program is to recognize and provide financial support for research efforts by outstanding cardiovascular scholars. This scholarship is to encourage junior faculty in the early phases of their careers in the field of cardiology. The program is intended for a physician with a strong interest in developing a career in cardiovascular translational research.
One year of previous interventional cardiology training is required. The duration of the program is one year. The awardee will develop skills and expertise in translating basic biological and device concepts into clinical application.
Goal: The overall goal of the program is to provide the clinical scientist (a physician) with the necessary scientific background that does not exist in today's curriculum. The program will enable the awardee to expedite scientific discovery to clinical application, ultimately benefitting the patient and society by providing science earlier and decreasing the developmental costs related to new devices and/or novel biologic therapies.
The program will cover the topics of:
• Basic science
• Preclinical science
• Clinical science and trial design
• Regulatory pathways (FDA) for IND (investigational new drug application) and IDE (investigational new device exemption)
The emphasis will be on biologics (stem cell therapy and genomics) and cardiovascular device development.
Objectives: The fellow will:
• Develop the skills and knowledge to take a scientific concept to the bedside
• Gain substantial knowledge about the steps in cardiovascular translational research
• Understand product development related to devices or biologics
• Learn about toxicology studies required on small and large animal models that serve for IND or IDE application
• Understand the statistical design and analysis required for toxicology studies, and phase I, II, and III clinical trials
• Learn about the regulatory pathways for and how to prepare an IND (Investigational Drug Application) and an IDE (Investigational Device Exemption)
• Understand fundraising, NIH grant application process, opportunities in the venture capital arena, and developing and maintaining relationships with industry
Eligibility: Applicants eligible for the award are those who:
• Have completed one year of previous interventional cardiology.
• Are members or are eligible to become a member of the ACC and ISCTR
• Will spend the duration of the Scholarship at an institution that has the ability to perform translational research (conducts both preclinical and clinical research) and can administer the curriculum found here:
http://www.cardiosource.org/~/media/Files/ACC/Membership/awards/ISCTR%20Curriculum.ashx
The Award: The award will offer $60,000 of salary support to begin July 1, 2014 and run through June 30, 2015.
Funding Source: The ACCF is grateful to Dignity Health St. John’s Hospital for their financial support for this award.
Nomination Procedure: Criteria for selection includes qualifications, background, interests, and commitment of the applicant.
How to Apply: The submission site for applications will open this summer. Please stay tuned for more information.
Deadline: September 23, 2013
For more information: Email Julia Berman or call 800-253-4636, ext. 6648.
Request for Application: A-T Children's Project
Attention Researchers:
Request for Application (RFA) for March 1, 2013 and September 1, 2013
Seed funding is now available for innovative proposals that seek to identify and validate biomarkers of A-T disease progression and that can be used to monitor therapeutic efficacy in clinical trials.
Please note that investigator-initiated proposals are also welcome for the March 1 and September 1 grant submission deadlines; however priority will be given to proposals that address the above referenced RFA.
We welcome investigators to contact Cynthia Rothblum-Oviatt, PhD, our Science Coordinator, if help is needed forming collaborations and/or obtaining reagents for A-T/ATM research.
Cynthia Rothblum-Oviatt, PhD Science Coordinator A-T Children's Project 5300 W. Hillsboro Blvd., Suite 105 Coconut Creek, FL 33073 cynthia@atcp.org Phone: 703-765-1223
Request for Proposals: Phase II Clinical Development of Novel, High-Potential Treatments for People with ALS
Letter of intent due: May 20, 2013
Submit letter of intent to researchgrants@alsa-national.org
The Massachusetts General Hospital Neurological Clinical Research Institute (NCRI) and The ALS Association are pleased to announce a call for phase II clinical trial applications for novel, high-potential treatments in Amyotrophic Lateral Sclerosis. The call for clinical study proposals is intended for academic-industry partnerships, including pharmaceutical, biotherapeutic/biotechnology companies, academic members of the Northeast ALS Consortium (NEALS), and ALS scientists throughout the world. A total of USD $800,000 (direct costs only) in NCRI/ALS Association clinical research support is available.
Potential Phase II clinical trials should include interventions that have:
A. a pharmacodynamics marker that can measure whether pathway of interest has been affected, and
B. a plan to collect samples for biomarker studies.
Applications will be reviewed by a joint NCRI and ALS Association steering committee and will be judged on:
-- Scientific rationale and merit, novelty, and the value of the project.
-- Availability of appropriate facilities and the technical ability to carry out the clinical study.
Funds will be awarded in the form of infrastucure support provided by NEALS and its Coordination Center, the NCRI, and funds for per subject fee, sample collection, pharmacodynamic marker testing and other trial related costs as needed. Applicants may apply for a combination of any of the following clinical research support services available through NEALS and the NCRI:
-- Project Management
-- Grants & Contracts Management
-- Data Management
-- Study Monitoring
-- Outcome Measure Development and Training
-- Biostatistical Support
-- Site Selection, Start Up, Regulatory Document Review, and Ongoing Site Management -- Site Trainings: Good Clinical Practice, Regulatory Compliance, and Site Management
The successful applicant will retain control of the trial as well as intellectual property relating to the therapeutic agent being investigated. The NCRI and The ALS Association are extremely well-positioned to work with both academic and industry partners to rapidly bring the best ALS science into clinical testing. Since infrastructure support is provided by this grant, applicants are required to contact NEALS/ALS Association prior to their grant submission to collaborate on the budget portion. Applicants may request the full $800,000 in NCRI/ALS Association research support or may request a smaller amount, depending on the appropriate needs of the proposed study.
Deadlines:
Letter of Intent: May 20, 2013
Notification to submit full application June 20, 2013
Full Application: August 15, 2013
Recipients Announced: October 2013
Award Starts: November 2013
Clinician-Scientist Development Three-Year Award in Parkinson's Disease
Co-sponsored by the American Brain Foundation and the Parkinson's Disease Foundation
Application Deadline: October 1, 2013
The American Brain Foundation, the foundation of the American Academy of Neurology, and the Parkinson’s Disease Foundation are pleased to announce a three-year Clinician-Scientist Development Award to support a clinician scientist’s research related to Parkinson’s Disease.
The three-year award will consist of an annual salary of $75,000 plus $5,000 in educational expenses, per year. Supplementation of the stipend with other grants or by the fellowship institution is permissible, but fellows may not accept other fellowships, similar awards, or have another source of support for more than 50 percent of their research salary during the first year of an American Brain Foundation Clinical Research Training Fellowship. If similar awards are obtained after completion of the first year of the American Brain Foundation Clinical Research Training Fellowship, fellows are required to submit a revised budget for review by executive members of the American Brain Foundation Research Committee or may need to forfeit the rest of the American Brain Foundation award. Only direct costs will be funded by this award.
ELIGIBILITY
1. Must be a neurologist interested in an academic career in clinical research.* Applicants must hold an MD, DO, or equivalent clinical degree from an accredited institution, and must be licensed to practice medicine in the United States.
2. Applicants must have completed residency training but be less than seven years from completion of residency when funding begins.
3. There is no citizenship requirement; however, the individual applying for the award must be licensed to practice medicine in the United States at the time of application.
Clinical research is defined as ”patient-oriented research conducted with human subjects, or translational research specifically designed to develop treatments or enhance diagnosis of neurological disease. These areas of research include epidemiologic or behavioral studies, clinical trials, studies of disease mechanisms, the development of new technologies, and health services and outcomes research.” Disease-related studies not directly involving humans or human tissue also are encouraged if the primary goal is the development of therapies, diagnostic tests, or other tools to prevent or mitigate neurological disease.
For More Information
Kristin Roehl
Grants Program Manager kroehl@aan.com (612) 928-6082
Clinician-Scientist Development Three-Year Award in Myasthenia Gravis and Related Disorders of the Neuromuscular Junction
Cosponsored by the American Brain Foundation and the Myasthenia Gravis Foundation of America
The American Brain Foundation, the foundation of the American Academy of Neurology, and the Myasthenia Gravis Foundation of America are pleased to announce a three-year Clinician-Scientist Development Award to support a clinician scientist’s research related to myasthenia gravis. The award aims to recognize the importance of good clinical research and encourage young investigators in clinical studies.
The three-year award will consist of an annual salary of $75,000 plus $5,000 in educational expenses, per year.
Supplementation of the stipend with other grants or by the fellowship institution is permissible, but fellows may not accept other fellowships, similar awards, or have another source of support for more than 50 percent of their research salary during the first year of an American Brain Foundation Clinical Research Training Fellowship. If similar awards are obtained after completion of the first year of the American Brain Foundation Clinical Research Training Fellowship, fellows are required to submit a revised budget for review by executive members of the American Brain Foundation Research Committee or may need to forfeit the rest of the American Brain Foundation award. Only direct costs will be funded by this award.
1. For the purpose of this fellowship, clinical research is defined as “patient-oriented research conducted with human subjects, or translational research specifically designed to develop treatments or enhance diagnosis of neurological disease. These areas of research include epidemiologic or behavioral studies, clinical trials, studies of disease mechanisms, the development of new technologies, and health services and outcomes research.” Disease-related studies not directly involving humans or human tissue also are encouraged if the primary goal is the development of therapies, diagnostic tests, or other tools to prevent or mitigate neurological diseases.
2. Applicant must be an AAN member interested in an academic career in clinical research who has completed residency, fellowship, or a post-doctoral fellowship (for a PhD) within the past five years. Those early in their clinical research careers will be given priority.
Susan S. Spencer Clinical Research Training Fellowship in Epilepsy
Sponsored by the American Brain Foundation, the American Epilepsy Society, and the Epilepsy Foundation
The American Brain Foundation, the foundation of the American Academy of Neurology, is pleased to announce a two-year fellowship to support clinical research training in the field of epilepsy. The fellowship is supported by the American Brain Foundation, the American Epilepsy Society, and the Epilepsy Foundation.
Each fellowship will consist of a commitment of $55,000 per year for two years, plus $10,000 per year for tuition to support formal education in clinical research methodology at the applicant’s institution or elsewhere.
Supplementation of the stipend with other grants or by the fellowship institution is permissible, but fellows may not accept other fellowships, similar awards, or have another source of support for more than 50 percent of their research salary during the first year of an American Brain Foundation Clinical Research Training Fellowship. If similar awards are obtained after completion of the first year of the American Brain Foundation Clinical Research Training Fellowship, fellows are required to submit a revised budget for review by executive members of the American Brain Foundation Research Committee or may need to forfeit the rest of the American Brain Foundation award.
Clinical Research Training Fellowship
Sponsored by the American Brain Foundation and the American Academy of Neurology
The American Brain Foundation, the foundation of the American Academy of Neurology, is pleased to announce up to ten two-year fellowships to support clinical research training in the neurosciences. The fellowships are supported by the American Brain Foundation and the American Academy of Neurology.
2. Applicant must be an AAN member interested in an academic career in clinical research who has completed residency or a post-doctoral fellowship (for a PhD) within the past five years. Those early in their clinical research careers will be given priority.
Clinical Research Training Fellowship in the Neurological Application of Neurotoxins
Funded by the Allergan Foundation
The American Brain Foundation, the foundation of the American Academy of Neurology, is pleased to announce two two-year fellowships to support clinical research training on the neurological application of neurotoxins towards the treatment of neurological conditions and patient care. These fellowships are funded by the Allergan Foundation.
Clinical Research Training Fellowship in Ataxia
Sponsored by the American Brain Foundation and the National Ataxia Foundation
The American Brain Foundation, the foundation of the American Academy of Neurology, is pleased to announce a two-year fellowship to support clinical research training in the field of ataxia. The fellowship is supported by the American Brain Foundation and the National Ataxia Foundation. Each fellowship will consist of a commitment of $55,000 per year for two years, plus $10,000 per year for tuition to support formal education in clinical research methodology at the applicant’s institution or elsewhere. Supplementation of the stipend with other grants or by the fellowship institution is permissible, but fellows may not accept other fellowships, similar awards, or have another source of support for more than 50 percent of their research salary during the first year of an American Brain Foundation Clinical Research Training Fellowship. If similar awards are obtained after completion of the first year of the American Brain Foundation Clinical Research Training Fellowship, fellows are required to submit a revised budget for review by executive members of the American Brain Foundation Research Committee or may need to forfeit the rest of the American Brain Foundation award. Only direct costs will be funded by this award.
12next
